Single-cell characterization of peripheral blood mononuclear cells from vedolizumab-treated patients with Crohn's disease identifies response-associated differences among the plasmacytoid dendritic cell and classical monocyte populations.
Andrew Y. F. Li Yim(Amsterdam University Medical Centers), Peter Henneman(University of Amsterdam), Wouter J. de Jonge(University of Bonn), Alex Adams(Edinburgh Genomics), Iris Admiraal-van den Berg(Amsterdam University Medical Centers), Ishtu Hageman(Amsterdam University Medical Centers), Jack Satsangi(Western General Hospital), V Joustra(Amsterdam University Medical Centers), Geert D’Haens(Amsterdam University Medical Centers), Mohammed Ghiboub(Amsterdam UMC Location University of Amsterdam), Marja E. Jakobs(University of Amsterdam), Caroline Verseijden, Evgeni Levin(Horse Hospital), Ahmed M I Elfiky(GlaxoSmithKline (United Kingdom)), Jan Verhoeff, Susan Kenter(Amsterdam University Medical Centers), Marcel M. A. M. Mannens(Center for Human Genetics)
Cited by 2
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
|Gastroenterology|1998|865